Lantern Pharma
LTRN
LTRN
21 hedge funds and large institutions have $5.14M invested in Lantern Pharma in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
21
Holding in Top 10
–
Calls
$58K
Puts
$2K
Top Buyers
| 1 | +$145K | |
| 2 | +$58.7K | |
| 3 | +$16.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.87K |
| 5 |
CWM
Cranbrook Wealth Management
Bloomfield Hills,
Michigan
|
+$3.46K |
Top Sellers
| 1 | -$91.4K | |
| 2 | -$73K | |
| 3 | -$63.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$40.3K |
| 5 |
RAM
Redmond Asset Management
Henrico,
Virginia
|
-$5.72K |